Clinical Trials in Waterloo, United States
Locations / Waterloo, United States
Delta Trials records 219 clinical trials conducted in Waterloo, United States, making it a notable site of clinical research activity. These trials across 359 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 32 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Waterloo has changed over time.
219
Total Trials
359
Conditions
32
Terminated since 2020
Browse by condition (359 total)
- Breast cancer 17 trialsAll Breast cancer trials
- Non-small cell lung cancer 11 trialsAll Non-small cell lung cancer trials
- Diabetes mellitus, type 2 11 trialsAll Diabetes mellitus, type 2 trials
- All Recurrent squamous cell lung carcinoma trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials
- Cardiovascular disease 6 trialsAll Cardiovascular disease trials
- Lung cancer 6 trialsAll Lung cancer trials
- Prostate cancer 5 trialsAll Prostate cancer trials
- Atrial fibrillation 5 trialsAll Atrial fibrillation trials
- Dyslipidemia 5 trialsAll Dyslipidemia trials
- Recurrent breast carcinoma 4 trialsAll Recurrent breast carcinoma trials
- Chronic lymphocytic leukemia 4 trialsAll Chronic lymphocytic leukemia trials
- Colorectal cancer 4 trialsAll Colorectal cancer trials
- Ulcerative colitis 4 trialsAll Ulcerative colitis trials
- Hypertension 4 trialsAll Hypertension trials
- Type 2 diabetes mellitus 4 trialsAll Type 2 diabetes mellitus trials
- Stroke 4 trialsAll Stroke trials
- Esophageal cancer 3 trialsAll Esophageal cancer trials
- Breast carcinoma 3 trialsAll Breast carcinoma trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials